396 related articles for article (PubMed ID: 20956947)
1. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
[TBL] [Abstract][Full Text] [Related]
2. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
3. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
4. Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks.
Kim AJ; Kim HJ; Jee HJ; Song N; Kim M; Bae YS; Chung JH; Yun J
Biochim Biophys Acta; 2011 Jun; 1813(6):1230-8. PubMed ID: 21440578
[TBL] [Abstract][Full Text] [Related]
5. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells.
Murakawa Y; Sonoda E; Barber LJ; Zeng W; Yokomori K; Kimura H; Niimi A; Lehmann A; Zhao GY; Hochegger H; Boulton SJ; Takeda S
Cancer Res; 2007 Sep; 67(18):8536-43. PubMed ID: 17875693
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
[TBL] [Abstract][Full Text] [Related]
8. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
9. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-proteasome pathway modulates mouse oocyte meiotic maturation and fertilization via regulation of MAPK cascade and cyclin B1 degradation.
Huo LJ; Fan HY; Zhong ZS; Chen DY; Schatten H; Sun QY
Mech Dev; 2004 Oct; 121(10):1275-87. PubMed ID: 15327787
[TBL] [Abstract][Full Text] [Related]
11. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
Choi YH
Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
[TBL] [Abstract][Full Text] [Related]
12. Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress. Proteasome inhibitors induce nuclear ribonucleoprotein inclusions that accumulate several key factors of neurodegenerative diseases and cancer.
Latonen L
Bioessays; 2011 May; 33(5):386-95. PubMed ID: 21425306
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition.
Jiang HY; Wek RC
J Biol Chem; 2005 Apr; 280(14):14189-202. PubMed ID: 15684420
[TBL] [Abstract][Full Text] [Related]
15. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis.
Gama V; Yoshida T; Gomez JA; Basile DP; Mayo LD; Haas AL; Matsuyama S
Exp Cell Res; 2006 Feb; 312(4):488-99. PubMed ID: 16368436
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes.
Joshi-Barve S; Barve SS; Butt W; Klein J; McClain CJ
Hepatology; 2003 Nov; 38(5):1178-87. PubMed ID: 14578856
[TBL] [Abstract][Full Text] [Related]
18. Potential roles for ubiquitin and the proteasome during ribosome biogenesis.
Stavreva DA; Kawasaki M; Dundr M; Koberna K; Müller WG; Tsujimura-Takahashi T; Komatsu W; Hayano T; Isobe T; Raska I; Misteli T; Takahashi N; McNally JG
Mol Cell Biol; 2006 Jul; 26(13):5131-45. PubMed ID: 16782897
[TBL] [Abstract][Full Text] [Related]
19. p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner.
Karni-Schmidt O; Zupnick A; Castillo M; Ahmed A; Matos T; Bouvet P; Cordon-Cardo C; Prives C
J Cell Sci; 2008 Dec; 121(Pt 24):4098-105. PubMed ID: 19033390
[TBL] [Abstract][Full Text] [Related]
20. Ataxia telangiectasia-mutated, a DNA damage-inducible kinase, contributes to high NaCl-induced nuclear localization of transcription factor TonEBP/OREBP.
Zhang Z; Ferraris JD; Irarrazabal CE; Dmitrieva NI; Park JH; Burg MB
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F506-11. PubMed ID: 15840767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]